Will RX IB consolidate in the future?

Shower thought, but given the limited amount of firms in the space, is there a chance that we could see the smaller players merge to form larger firms? Or is it possible that the smaller firms could be acquired by RX consulting firms "tuck ins" to strengthen their in-house IB teams (seems to be a bit of that happening right now). Or is it more likely to be a larger amount of firms in the space in the near future?

2 Comments
 

The future of RX IB consolidation is an interesting topic. Based on the most helpful WSO content, here are some insights:

  1. Limited Number of Firms and Expertise: Restructuring (RX) is a niche field with fewer groups compared to M&A. The technical and specialized nature of RX means that there are not many bankers or firms with deep expertise in this area. This exclusivity could make consolidation appealing for smaller players looking to scale or compete with larger firms.

  2. Potential for Mergers or Acquisitions: Smaller RX firms merging or being acquired by larger RX consulting firms is plausible. RX consulting firms like A&M and FTI already play significant roles in restructuring processes, often collaborating with RX bankers. Acquiring smaller RX IB firms could strengthen their in-house capabilities and provide a more comprehensive service offering.

  3. Counterarguments Against Consolidation:

    • Cyclicality of RX: RX thrives during economic downturns but tends to run lean during bull markets. This countercyclical nature might discourage large-scale consolidation, as firms may prefer to remain agile and specialized rather than expand significantly.
    • Referral Ecosystem: RX bankers, consultants, and legal counsel often act as referral sources for one another. This interconnected ecosystem might reduce the need for consolidation, as firms can collaborate without merging.
  4. Future Growth of Firms: While consolidation is possible, the growth of new firms in the RX space is also likely. Economic cycles and the increasing complexity of distressed situations could create opportunities for new entrants, especially those offering innovative or specialized services.

In summary, while consolidation is a possibility, the niche and cyclical nature of RX, combined with the existing referral ecosystem, might limit the extent of such activity. At the same time, the space could see new players emerge, especially during periods of economic distress.

Sources: Pros & Cons Summary - Post-MBAs in Restructuring (RX) - any regrets?, Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups, Wharton kids favor restructuring/distressed investing?, Top Restructuring Groups 2016, Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 
Most Helpful

Eveniet pariatur doloremque similique. Voluptatem et in excepturi itaque totam minus beatae nam.

Necessitatibus nisi non hic et iste dolorum qui. Et et et quo ullam eos odit labore. Rerum repellendus non non perspiciatis sit. Exercitationem tempore hic numquam soluta enim id exercitationem. Deleniti iste magni rerum molestiae aliquam.

Dicta cum officiis nihil sed animi. Rerum non impedit est repellat voluptas voluptas temporibus. Quia quis possimus accusamus ut dignissimos nesciunt iste. Minima recusandae sunt minus iste.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • BMO Capital Markets 11 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”